Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
Clinical trial NCT00495079 · COMPLETED
Trial details
- NCT number
- NCT00495079
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2010-08-08
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.